Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $68.6500 (-0.25%) ($68.6500 - $68.6500) on Thu. Jul. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.17% (three month average) | RSI | 14 | Latest Price | $68.6500(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(46%) IBB(43%) XHB(41%) XAR(38%) UNG(37%) | Factors Impacting LGND price | LGND will decline at least -1.085% in a week (0% probabilities). TBT(-25%) VXX(-22%) UUP(-19%) XLU(-10%) VIXM(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.085% (StdDev 2.17%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $62.74(-8.61%) | Resistance Level | $72.68 | 5 Day Moving Average | $69.29(-0.92%) | 10 Day Moving Average | $70.4(-2.49%) | 20 Day Moving Average | $72.68(-5.54%) | To recent high | -13.8% | To recent low | 0% | Market Cap | $1.103b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |